252 related articles for article (PubMed ID: 12376447)
1. Bleeding risks of antithrombotic therapy.
Fitzmaurice DA; Blann AD; Lip GY
BMJ; 2002 Oct; 325(7368):828-31. PubMed ID: 12376447
[No Abstract] [Full Text] [Related]
2. Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.
Warkentin AE; Donadini MP; Spencer FA; Lim W; Crowther M
J Thromb Haemost; 2012 Apr; 10(4):512-20. PubMed ID: 22257078
[TBL] [Abstract][Full Text] [Related]
3. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
4. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
5. Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.
McFadyen JD; Peter K
Circ Res; 2017 Oct; 121(10):1133-1135. PubMed ID: 29074533
[No Abstract] [Full Text] [Related]
6. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
7. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
[TBL] [Abstract][Full Text] [Related]
8. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
Mooe T
Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
[No Abstract] [Full Text] [Related]
9. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
[TBL] [Abstract][Full Text] [Related]
10. Real risks of two common drugs.
Johns Hopkins Med Lett Health After 50; 1999 May; 11(3):3. PubMed ID: 10232088
[No Abstract] [Full Text] [Related]
11. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Prisco D
Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
[No Abstract] [Full Text] [Related]
12. Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
Gulati S; Solheim O; Carlsen SM; Øie LR; Jensberg H; Gulati AM; Madsbu MA; Giannadakis C; Jakola AS; Salvesen Ø
PLoS One; 2018; 13(8):e0202575. PubMed ID: 30138389
[TBL] [Abstract][Full Text] [Related]
13. How do we manage patients treated with antithrombotic therapy in the perioperative interval.
Bracey AW; Reyes MA; Chen AJ; Bayat M; Allison PM
Transfusion; 2011 Oct; 51(10):2066-77. PubMed ID: 21517891
[No Abstract] [Full Text] [Related]
14. Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Tay KH; Lane DA; Lip GY
Thromb Haemost; 2008 Dec; 100(6):955-7. PubMed ID: 19132214
[No Abstract] [Full Text] [Related]
15. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
16. Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting.
Kawai H; Watanabe E; Yamamoto M; Harigaya H; Sano K; Takatsu H; Muramatsu T; Naruse H; Sobue Y; Motoyama S; Sarai M; Takahashi H; Arakawa T; Kan S; Sugiura A; Murohara T; Ozaki Y
J Cardiol; 2015 Mar; 65(3):197-202. PubMed ID: 25266323
[TBL] [Abstract][Full Text] [Related]
17. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244
[TBL] [Abstract][Full Text] [Related]
18. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
[TBL] [Abstract][Full Text] [Related]
19. [Should warfarin and acetylsalicylic acid be withdrawn prior to tooth extraction?].
Løkken P; Skjelbred P
Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2498-9. PubMed ID: 16186871
[No Abstract] [Full Text] [Related]
20. Known knowns and known unknowns: risks associated with combination antithrombotic therapy.
Johnson S
Thromb Res; 2008; 123 Suppl 1():S7-11. PubMed ID: 18829070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
